Product Information
ALMOTRIPTAN MALATE 12.5 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $16.8566 per EA under NDC 00093526129. Its NADAC has been published 572 times since Oct 21, 2015.
FDA first approved this application on Jul 7, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093526129
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALMOTRIPTAN MALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078027FDA Approved
7/7/2015
TE Code
AB
On Market Since
7/7/2015
Pharmacological Classes
Price Statistics
The NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has been published 572 times since Oct 21, 2015, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.8566 per EA |
|---|---|
| All-time high | $31.3479 (Jan 13, 2016) |
| All-time low | $13.4937 (May 22, 2024) |
| 52-week high | $18.5589 |
| 52-week low | $16.8566 |
| Median price | $21.8661 |
| Average price | $22.1092 |
| Largest weekly change | +34.3% (Jun 19, 2024) |
| Weeks tracked | 572 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Almotriptan Malate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Almotriptan Malate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALMOTRIPTAN MALATE 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALMOTRIPTAN MALATE 12.5 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $16.8566 per EA (NDC 00093526129), effective Sep 30, 2026.
How has the price of ALMOTRIPTAN MALATE 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has declined 42.1%. It has been tracked across 572 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for ALMOTRIPTAN MALATE 12.5 MG TAB?
Since Oct 21, 2015, the NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has ranged from a low of $13.4937 (May 22, 2024) to a high of $31.3479 (Jan 13, 2016), with a median of $21.8661 per EA.
Are there cheaper alternatives to ALMOTRIPTAN MALATE 12.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ALMOTRIPTAN MALATE 12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALMOTRIPTAN MALATE 12.5 MG TAB?
ALMOTRIPTAN MALATE 12.5 MG TAB (NDC 00093526129) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.